nodgoРоссийский журнал детской гематологии и онкологии (РЖДГиО)Russian Journal of Pediatric Hematology and Oncology2311-12672413-5496LTD “Graphica”10.17650/2311-1267-2017-4-1-83-88nodgo-287Research ArticleСЛУЧАЙ ИЗ ПРАКТИКИCASE STUDYГетерогенность 4S стадии нейробластомы: мультидисциплинарный взглядHeterogeneity of neuroblastoma stage 4S: a multidisciplinary viewШаманскаяТ. В.ShamanskayaT. V.

117997, Москва, ул. Саморы Машела, 1

1 Samory Mashela St., Moscow, 117997

shamanskaya.tatyana@gmail.comКачановД. Ю.KachanovD. Yu.

117997, Москва, ул. Саморы Машела, 1

1 Samory Mashela St., Moscow, 117997

ФеоктистоваЕ. В.FeoktistovaE. V.

117997, Москва, ул. Саморы Машела, 1

1 Samory Mashela St., Moscow, 117997

ТерещенкоГ. В.TereshchenkoG. V.

117997, Москва, ул. Саморы Машела, 1

1 Samory Mashela St., Moscow, 117997

ЛикарьЮ. Н.LikarYu. N.

117997, Москва, ул. Саморы Машела, 1

1 Samory Mashela St., Moscow, 117997

МуфтаховаГ. М.MuftakhovaG. M.

117997, Москва, ул. Саморы Машела, 1

1 Samory Mashela St., Moscow, 117997

ТалыповС. Р.TalypovS. R.

117997, Москва, ул. Саморы Машела, 1

1 Samory Mashela St., Moscow, 117997

ВарфоломееваС. Р.VarfolomeevaS. R.

117997, Москва, ул. Саморы Машела, 1

1 Samory Mashela St., Moscow, 117997

ФГБУ «ННПЦ ДГОИ им. Дмитрия Рогачева» Минздрава РоссииРоссияDmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology, Ministry of Health of RussiaRussian Federation201701032017418388Copyright © Шаманская Т.В., Качанов Д.Ю., Феоктистова Е.В., Терещенко Г.В., Ликарь Ю.Н., Муфтахова Г.М., Талыпов С.Р., Варфоломеева С.Р., 20172017Шаманская Т.В., Качанов Д.Ю., Феоктистова Е.В., Терещенко Г.В., Ликарь Ю.Н., Муфтахова Г.М., Талыпов С.Р., Варфоломеева С.Р.Shamanskaya T.V., Kachanov D.Y., Feoktistova E.V., Tereshchenko G.V., Likar Y.N., Muftakhova G.M., Talypov S.R., Varfolomeeva S.R.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.nodgo.org/jour/article/view/287

4S стадия является уникальной и гетерогенной метастатической формой нейробластомы – наиболее частой экстракраниальной солидной опухоли детского возраста. Крайне важным является мультидисциплинарный подход к ведению данной группы пациентов, от момента постановки диагноза до выработки терапевтического плана и схемы динамического наблюдения.

4S stage is unique and heterogeneous metastatic neuroblastoma - the most common extracranial solid tumor of childhood. Extremely important is the multidisciplinary approach to the management of this group of patients, from diagnosis to the development of a therapeutic plan and scheme of dynamic observation.

нейробластомадети4S стадиясцинтиграфия с метайодбензилгуанидиномультразвуковая диагностикамагнитно-резонансная томографияполихимиотерапияneuroblastomachildrenstage 4Sscintigraphy with meta-iodobenzylguanidineultrasound diagnosticsmagnetic resonance imagingchemotherapyReferencesCheung N.K., Dyer M.A. Neuroblastoma: developmental biology, cancer genomics and immunotherapy. Nat Rev Cancer 2013;13(6):397–411.Cheung N.K., Dyer M.A. Neuroblastoma: developmental biology, cancer genomics and immunotherapy. Nat Rev Cancer 2013;13(6):397–411.Berthold F., Simon T. Clinical presentation. In: Neuroblastoma. Cheung N.-K., Cohn S., eds. Springer-Verlag, Berlin, Heidelberg, 2005. Pp. 63–86.Berthold F., Simon T. Clinical presentation. In: Neuroblastoma. Cheung N.-K., Cohn S., eds. Springer-Verlag, Berlin, Heidelberg, 2005. Pp. 63–86.Brodeur G.M., Pritchard J., Berthold F. et al. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 1993;11(8):1466–77.Brodeur G.M., Pritchard J., Berthold F. et al. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 1993;11(8):1466–77.Nour-Eldin N.E., Abdelmonem O., Tawfik A.M. et al. Pediatric primary and metastatic neuroblastoma: MRI findings: pictorial review. Magn Reson Imaging 2012;30(7):893–906.Nour-Eldin N.E., Abdelmonem O., Tawfik A.M. et al. Pediatric primary and metastatic neuroblastoma: MRI findings: pictorial review. Magn Reson Imaging 2012;30(7):893–906.Качанов Д.Ю., Шаманская Т.В., Муфтахова Г.М., Варфоломеева С.Р. Нейробластома 4S стадии. Вопросы гематологии/онкологии и иммунопатологии в педиатрии 2014;13(2):9–19. [Kachanov D.Yu., Shamanskaya T.V., Muftakhova G.M., Varfolomeeva S.R. Stage 4S neuroblastoma. Voprosy gematologii/onkologii i immunopatologii v pediatrii = Pediatric Hematology/ Oncology and Immunopathology 2014;13(2):9–19. (In Russ.)].Качанов Д.Ю., Шаманская Т.В., Муфтахова Г.М., Варфоломеева С.Р. Нейробластома 4S стадии. Вопросы гематологии/онкологии и иммунопатологии в педиатрии 2014;13(2):9–19. [Kachanov D.Yu., Shamanskaya T.V., Muftakhova G.M., Varfolomeeva S.R. Stage 4S neuroblastoma. Voprosy gematologii/onkologii i immunopatologii v pediatrii = Pediatric Hematology/ Oncology and Immunopathology 2014;13(2):9–19. (In Russ.)].Pagès P.M., Dufour C., Fasola S. et al. Bilateral adrenal neuroblastoma. Pediatr Blood Cancer 2009;52(2):196–202.Pagès P.M., Dufour C., Fasola S. et al. Bilateral adrenal neuroblastoma. Pediatr Blood Cancer 2009;52(2):196–202.Katzenstein H.M., Bowman L.C., Brodeur G.M. et al. Prognostic significance of age, MYCN oncogene amplification, tumor cell ploidy, and histology in 110 infants with stage D(S) neuroblastoma: the pediatric oncology group experience--a pediatric oncology group study. J Clin Oncol 1998;16(6):2007–17.Katzenstein H.M., Bowman L.C., Brodeur G.M. et al. Prognostic significance of age, MYCN oncogene amplification, tumor cell ploidy, and histology in 110 infants with stage D(S) neuroblastoma: the pediatric oncology group experience--a pediatric oncology group study. J Clin Oncol 1998;16(6):2007–17.Schleiermacher G., Michon J., Ribeiro A., et al. Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/ disseminated neuroblastoma (a SIOPEN collaborative study). Br J Cancer 2011;105(12):1940–8.Schleiermacher G., Michon J., Ribeiro A., et al. Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/ disseminated neuroblastoma (a SIOPEN collaborative study). Br J Cancer 2011;105(12):1940–8.Massaron S., Seregni E., Luksch R. et al. Neuron-specific enolase evaluation in patients with neuroblastoma. Tumour Biol 1998;19(4):261–8.Massaron S., Seregni E., Luksch R. et al. Neuron-specific enolase evaluation in patients with neuroblastoma. Tumour Biol 1998;19(4):261–8.Balassy C., Navarro O.M., Daneman A. Adrenal masses in children. Radiol Clin North Am 2011;49(4):711–27.Balassy C., Navarro O.M., Daneman A. Adrenal masses in children. Radiol Clin North Am 2011;49(4):711–27.Brisse H.J., McCarville M.B., Granata S. et al.; International Neuroblastoma Risk Group Project. Guidelines for imaging and staging of neuroblastic tumors: consensus report from the International Neuroblastoma Risk Group Project. Radiology 2011;261(1):243–57.Brisse H.J., McCarville M.B., Granata S. et al.; International Neuroblastoma Risk Group Project. Guidelines for imaging and staging of neuroblastic tumors: consensus report from the International Neuroblastoma Risk Group Project. Radiology 2011;261(1):243–57.Rufini V., Shulkin B. The evolution in the use of MIBG in more than 25 years of experimental and clinical applications. Q J Nucl Med Mol Imaging 2008;52(4):341–50.Rufini V., Shulkin B. The evolution in the use of MIBG in more than 25 years of experimental and clinical applications. Q J Nucl Med Mol Imaging 2008;52(4):341–50.Mueller W.P., Coppenrath E., Pfluger T. Nuclear medicine and multimodality imaging of pediatric neuroblastoma. Pediatr Radiol 2013;43(4):418–27.Mueller W.P., Coppenrath E., Pfluger T. Nuclear medicine and multimodality imaging of pediatric neuroblastoma. Pediatr Radiol 2013;43(4):418–27.Guglielmi M., De Bernardi B., Rizzo A. et al. Resection of primary tumor at diagnosis in stage IV-S neuroblastoma: does it affect the clinical course? J Clin Oncol 1996;14(5):1537–44.Guglielmi M., De Bernardi B., Rizzo A. et al. Resection of primary tumor at diagnosis in stage IV-S neuroblastoma: does it affect the clinical course? J Clin Oncol 1996;14(5):1537–44.NB2004 protocol. Berthold F (principal investigator). http://www.kinderkrebsinfo.de/dlja_specialistov/protokoly_gpoh/pohkinderkrebsinfotherapiestudien/nb2004/index_rus.html [cited 2016 March 15].NB2004 protocol. Berthold F (principal investigator). http://www.kinderkrebsinfo.de/dlja_specialistov/protokoly_gpoh/pohkinderkrebsinfotherapiestudien/nb2004/index_rus.html [cited 2016 March 15].Holsten T., Schuster T., Grabhorn E. et al. Liver transplantation as a potentially lifesaving measure in neuroblastoma stage 4S. Pediatr Hematol Oncol 2017:1–7. [Epub ahead of print].Holsten T., Schuster T., Grabhorn E. et al. Liver transplantation as a potentially lifesaving measure in neuroblastoma stage 4S. Pediatr Hematol Oncol 2017:1–7. [Epub ahead of print].van Noesel M.M., Hählen K., Hakvoort-Cammel F.G., Egeler R.M. Neuroblastoma 4S: a heterogeneous disease with variable risk factors and treatment strategies. Cancer 1997;80(5):834–43.van Noesel M.M., Hählen K., Hakvoort-Cammel F.G., Egeler R.M. Neuroblastoma 4S: a heterogeneous disease with variable risk factors and treatment strategies. Cancer 1997;80(5):834–43.

The authors declare that there are no conflicts of interest present.